The COVID-19 vaccines currently authorized by the Federal Drug Administration have proved to be far more effective than the wildest dreams of public health officials early in the pandemic. But Sidi Bencherif thinks we could do even better. And the assistant professor of chemical engineering at Northeastern has the data […]
Baricitinib demonstrates sustained long-term efficacy in patients with moderate-to-severe atopic dermatitis, according to a study published online May 12 in JAMA Dermatology. Jonathan I. Silverberg, M.D., from the George Washington University School of Medicine in Washington, D.C., and colleagues evaluated the long-term (68 weeks) efficacy of baricitinib in adults with […]